Metenolone Enanthate is an injectable anabolic-androgenic steroid (AAS) belonging to the dihydrotestosterone (DHT) group. Metenolone Enanthate is also known as primobolan. This drug is a single long acting ester steroid. It is one of the mildest anabolic steroids available in the market. Methenelone is low in androgen levels. This drug is used to promote weight gain following extensive surgery, severe trauma, chronic infection, and in other cases that result in inadequate weight gain or maintenance.

The global Metenolone Enanthate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Metenolone Enanthate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metenolone Enanthate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Dragon Pharmaceuticals Inc.
Wellona Pharma
Geneza Pharmaceuticals
Kosher Pharmaceuticals
British Dragon Pharmaceuticals
International Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Oral
Injectable

Segment by Application
Bodybuilding
Sports
Surgery
Others